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Abstract 
Knowledge of the accuracy of dose calculations in intensity-modulated radiotherapy 
of the head and neck is essential for clinical confidence in these highly conformal 
treatments.  High dose gradients are frequently placed very close to critical structures, 
such as the spinal cord, and good coverage of complex shaped nodal target volumes is 
important for long term-local control.   
 
A phantom study is presented comparing the performance of standard clinical pencil-
beam and collapsed-cone dose algorithms to Monte Carlo calculation and three-
dimensional gel dosimetry measurement. All calculations and measurements are 
normalized to the median dose in the primary planning target volume, making this a 
purely relative study.  The phantom simulates tissue, air and bone for a typical neck 
section and is treated using an inverse-planned 5-field IMRT treatment, similar in 
character to clinically used class solutions.  
 
Results indicate that the pencil-beam algorithm fails to correctly model the relative 
dose distribution surrounding the air cavity, leading to an overestimate of the target 
coverage.  The collapsed-cone and Monte Carlo results are very similar, indicating 
that the clinical collapsed-cone algorithm is perfectly sufficient for routine clinical 
use. The gel measurement shows generally good agreement with the collapsed-cone 
and Monte Carlo calculated dose, particularly in the spinal cord dose and nodal target 
coverage, thus giving greater confidence in the use of this class solution. 
 
Key words:  IMRT dose calculation accuracy, gel dosimetry, Monte Carlo 
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1. Introduction 
Radiotherapy is a crucial component of the modern multidisciplinary approach to 
treatment of cancers in the head-and-neck.  However, the close proximity of several 
critical organs-at-risk to often large and complex-shaped target volumes makes 
accurate treatment of this region challenging [1].  The use of intensity-modulated 
radiotherapy (IMRT) has been shown to give improved target coverage and reduced 
normal-tissue doses compared to conventional techniques [2–4].   
 
For target volumes in the base of tongue and oral cavity IMRT can be used to keep 
the dose to the parotid glands low whilst still maintaining good target coverage [5,6], 
leading to reduced xerostomia and generally improved quality of life after treatment 
[7,8].  It has also been noted that reduced cochlea dose may well correlate with 
reductions in radiotherapy-induced hearing loss [9]. 
 
Target volumes are often comprised of a region containing a primary tumour together 
with prophylactically treated lymph-node chains.  IMRT has been shown to be 
effective in these cases, delivering a ―simultaneous, integrated boost‖ with differing 
dose levels for the primary and nodal targets [10,11] that gives superior homogeneity 
and reduced dose to surrounding critical structures compared to standard techniques.  
When adequately defined target volumes are correctly treated very good local control 
rates can be achieved (2-year actuarial locoregional control of 85% for parotid-
sparing IMRT) [3] with failure predominantly within the CTV (probably attributed to 
hypoxic, radiation resistant volumes within the tumour). 
 
A major physical challenge in IMRT planning for head-and-neck cases is accurate 
dose calculation.  The large and complex shaped target volumes often cause inverse-
planning systems to produce highly complex beams comprised of many small, often 
off-axis beam segments.  Three types of dose calculation algorithm are available, the 
most common is the pencil-beam (PB) model, which is fast—and hence suitable for 
iterative optimization techniques that require many repeated calculations—but known 
to be inaccurate, particularly in inhomogeneous media.  Convolution/superposition 
methods, such as the collapsed-cone convolution (CC) offer improved accuracy at the 
expense of reduced calculation speed, and are becoming increasingly clinically 
available.  Finally, Monte Carlo (MC) calculation techniques should offer the most 
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robust results, subject to the accuracy of the linac—and patient—models and 
statistical noise, but until recently have only been available in a research setting 
because of their prohibitively large computational demands. 
 
Two kinds of error can be present within the inverse-planned solution i) systematic 
errors in the dose calculation itself and ii) ―convergence errors‖ where the 
approximations in the dose calculation prevent the optimization from reaching the 
global minimum [12].  If the treatment plan is clinically acceptable, this second error 
is not particularly significant, but it is essential to know the limits of accuracy of the 
primary dose calculation, especially where critical structures lie close to high-dose 
volumes. 
 
For typical head-and-neck IMRT treatments, the systematic errors in dose calculation 
for individual fields can be quite large but when the entire treatment is considered the 
agreement between different dose calculations is generally good, with PTV coverage 
changing by no more than 2% of Dmax [13] and dosimetric agreement within 3% of  
Dmax [14–17].  Serious discrepancies (>5% of Dmax) have been shown to occur outside 
of the target volume, where head scatter and collimator transmission provide major 
contributions to the dose distribution [14,18].  In these cases, MC calculations—
which correctly model beam transmission through the entire collimation system—are 
expected to provide more accurate results than PB or CC techniques.  Dose to critical 
structures adjacent to the high-dose volume is of particular concern clinically, so it is 
important to know the limits of accuracy of the various calculation methods available. 
 
Gel dosimeters consist of radiation sensitive materials held in place within a gel and 
have recently been implemented clinically in our institution [19]. After irradiation a 
measurable change in the active materials occurs which is proportional to the 
radiation dose, thus preserving a spatial record of the radiation dose. Although there 
have been many variations of gel dosimeter reported by numerous authors, the main 
types studied to date are the Fricke gel dosimeter suggested by [20], the polymer gel 
dosimeter with gelatin [21] termed either BANG (Bis-acrylamide, Acrylamide, 
Nitrogen, Gelatin) or PAG (polyacrylamide gel) (BANG

 later became a registered 
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trademark), and recently the normoxic MAGIC gel (Methacrylic and Ascorbic acid in 
Gelatin Initiated by Copper) [22].  
 
Gel dosimetry has been employed previously for examining radiation treatment for 
cancer of the head and neck. In the first instance De Deene et al [23] produced a 
homogenous PVC walled phantom with the wall shape modelled on the neck region 
of a Rando phantom. The gel used in this case was a PAG. Comparison of gel 
measurements were made with those of film and TLDs placed in an Alderson Rando 
phantom. Differences in the techniques were attributed to the homogeneity of the gel 
phantom compared to heterogeneity in the Rando phantom (trachea). Gustavsson et al 
[24] also used a PAG in a phantom based on the Rando phantom, however a model 
trachea was added and the phantom wall materials were produced from Barex. In this 
case it was found that, around the model trachea, the gel showed a higher dose than 
the planning system and the authors attributed the discrepancy to a number of factors 
including a possible non-linearity of dose response of the PAG due to oxygen 
contamination, deformation of the gel and previously report deviations between 
measured doses and doses calculated close to low-density heterogeneities [25]. 
 
In this paper we present comparisons of dose calculations carried out using PB, CC 
and MC algorithms with 3D gel dosimetry measurements for an inhomogeneous 
geometric neck phantom.  The PB algorithm is used to inverse-plan a ―typical‖ IMRT 
beam arrangement, using our clinical class solution of 5 co-planar beams.  The 
expected dose distribution is then recalculated using CC and MC algorithms using the 
PB-optimised beams and compared to measurement. 
 
 
2. Materials and Method 
2.1 Phantom design 
A cylindrical phantom was produced from 1 mm thick Barex sheets. Although 
MAGIC gels are designed for production in normal atmospheric conditions, diffusion 
of oxygen through the gel after production may lead to inaccuracies when reading the 
gel [22]. As Barex has a low diffusion coefficient for oxygen [26] it was chosen as the 
phantom wall material.  The phantoms had a diameter of 120 mm and height of 
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100 mm as shown in figures 1 and 2. A 30 mm diameter model oesophagus insert was 
added and had a filling hole such that the oesophagus could be filled with air during 
irradiation to closer simulate realistic conditions, and water during MR imaging to 
reduce artefacts. The model spinal bone insert was manufactured from 61% weight 
epoxy resin, 24% hardener and 15% calcium carbonate powder (Sigma, London) as 
described by Gum et al [27]. The bone insert had an external diameter of 40 mm and 
had a 15 mm hole through the central axis in which gel could be added to measure 
dose to a simulated spinal cord. Both surfaces of the spine insert were lined with 
Barex as preliminary testing indicated that MAGIC gel is extremely corrosive to the 
epoxy material and caused degradation within hours. 
2.2 Treatment planning 
The phantoms were water filled—leaving the model oesophagus air filled—and CT 
scanned (39 slices, slice thickness 2.5 mm, pixel size 0.5  0.5 mm2) with the CT 
coordinate system marked on the phantom for reference.  The CT image set was 
transferred to the TMS treatment planning system (Nucletron B.V., Veenendaal, The 
Netherlands) and three planning target volumes were drawn that are broadly similar to 
those used in clinical IMRT for tumors of the larynx with nodal involvement.  The 
primary PTV—treated  to 65 Gy—surrounds the oesophagus and the two nodal 
PTVs—treated to 54 Gy—curve round the sides of the neck, surrounding the spine.  
For this simplified phantom case, all PTVs were extended in a cylindrically 
symmetrical fashion.  The total axial length of the primary PTV was 4 cm, with the 
nodal PTVs being 5 cm long.  (See figure 2). 
 
Our clinical 5-field class solution was applied with beams at 0, 55, 145, 212 and 
305. The two posterior beams were constrained so that the spinal cord was 
completely blocked in the beam‘s-eye-view.  A multiple-static-field IMRT plan was 
generated by inverse planning using 10 intensity levels and a maximum of 15 
segments per beam, constrained so that no segment should be smaller than 3 MU.  
The objectives of the inverse planning were to deliver median doses of 65 Gy to the 
primary PTV and 54 Gy to the nodal PTV whilst keeping the maximum spinal cord 
dose below 42 Gy.  The standard TMS PB dose calculation was used during 
optimization, calculating on a 2.5  2.5  3.0 mm3 grid.  The dose calculation was 
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then repeated using the TMS CC calculation for the PB-optimised IMRT beams.  
Both the PB and CC calculations were performed with exactly the same number of 
monitor units per beam. 
2.3 Monte Carlo calculation 
Monte Carlo dose calculation in radiotherapy involves developing a model of the 
treatment linear accelerator (linac) that reproduces standard commissioning data. The 
Monte Carlo commissioning of the treatment linac consisted of matching calculated 
and experimental results for both percentage depth dose (PDD) and off-axis ratio 
(OAR) obtained from standard open-fields (44, 88, 1010, 1515, 2020, 3030, 
4040 cm2) measured in a standard water tank [28]. Such matching was performed to 
commission the Monte Carlo calculation method at the RMNHSFT, where the 
percentage depth dose and off-axis ratio matching obtained was respectively 1% and 
2% / 2 mm.  A calibration factor to convert MC units of dose per incident particle into 
dose per monitor unit was obtained by taking the ratio of the measured dose to the 
MC dose for a 1010 cm2 field with source-surface distance of 100 cm and a depth of 
5 cm. 
 
In the Monte Carlo phantom dose calculation, four materials were used from the 
EGSnrc/ICRU materials database to convert the computed tomography (CT) 
Hounsfield numbers into cross sectional data: AIR521ICRU, LUNG521ICRU, 
ICRUTISSUE521ICRU and ICRPBONE521ICRU [29]. The CT Hounsfield numbers 
were converted into materials and cross-sectional data using the Kawrakow, Fippel 
and Friedrich [29], approach. The electron (AE and ECUT) and photon (AP and 
PCUT) cut-off energies used were respectively 561 keV and 10 keV. The MC 
phantom dose uncertainty was below 3% for voxels within and closely surrounding 
the PTV region, and within 4-5% for organ-at-risk voxels distant from the PTV. 
 
2.4 Film-based verification 
The method routinely used in our clinic for performing patient-specific verification of 
IMRT dose distributions is to deliver the patient-optimised beams to radiographic film 
in a homogenous phantom.  These beams are also applied to a model of the phantom 
in the treatment planning system and the expected dose calculated.  Isodose contour 
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plots and gamma maps of the measured and calculated distributions are then 
compared. 
 
Films measurements of the dose distribution described above were also carried out as 
a consistency check of the method.  A homogenous water phantom consisting of two 
120 mm diameter, water-filled cylinders was placed in exactly the same treatment 
position as the phantom illustrated in figure 1.  A single sheet of Kodak EDR2 film 
was placed in a transverse plane at the centre of the phantom.  A single depth-dose 
calibration was exposed immediately after the phantom delivery (further details of the 
film verification technique can be found in Adams et al [30]).  The film was digitised 
using a Vidar VXR-12 (Vidar Systems Corporation, Herndon, VA, USA) scanner 
with the OmniPro I‘mRT software (Scanditronix Wellhöfer GmbH, Schwarzenbruck, 
Germany).  Dose calculations were also performed on a homogenous model for 
comparison with these film results only.   
2.5 Polymer gel dosimeter manufacture 
The gel dosimeters used in this experiment were ‗MAGIC‘ gels described by Fong et 
al [22] and manufactured in normal atmospheric conditions. They consisted of 82.8% 
(by weight) HPLC grade water (BDH Laboratory Supplies, Poole, UK), 8% Type A 
300 bloom gelatin (Sigma, London), 9% methacrylic acid (Sigma, London), 0.0352% 
ascorbic acid (Sigma, London), 0.002% CuSO4.5H2O (Sigma, London) and 0.2% 
Hydroquinone (Sigma, London). The manufacturing process was similar to that 
described by Fong et al [22], with the weight of each chemical scaled to make an 
appropriate volume of gel dosimeter per phantom. After manufacture the polymer gel 
dosimeters were poured into phantoms and stored at 4C overnight prior to 
irradiation. The MAGIC gel was chosen as it has been shown to have an 
approximately linear dose response of transverse relaxation rate (R2) to a high dose 
range [19,22,31]. 
2.6 Irradiation 
The phantoms were aligned using the marks made during CT scanning and irradiated 
with the IMRT plan as described above on an Elekta SL15 linear accelerator.  To 
improve the signal-to-noise in the gel dosimetry measurement, all doses were scaled 
up to deliver a median dose of 10 Gy to the primary PTV. 
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2.7 Magnetic resonance imaging 
After irradiation the phantoms were placed in the MRI magnet room overnight to 
stabilize their temperature prior to scanning. The air cavity was filled with water to 
avoid artefacts in the dose image and the phantom was scanned on a Siemens Vision 
1.5 T scanner with a 16-echo spin echo sequence using a standard Siemens sequence 
(se_16_360b130.wkc). Echo spacing was 22.5 ms with repetition time of 2000 ms. 
Imaging parameters included slice thickness of 5 mm separated by 2.5 mm, field size 
of 256256 mm2 and image size of 256256 pixels2. After scanning was complete an 
R2 map was calculated on a pixel by pixel basis by fitting an exponential function to 
the signal decay of the 16 base images. The R2 images were then transferred to a 
personal computer where they were converted to percentage dose images [19] using 
Matlab software (The Mathworks Inc). To obtain the R2 value at 0 % dose an image 
was obtained of an unirradiated region of the phantom. 
 
 
3. Results and Discussion 
The result of this study was to produce four, three-dimensional dose distributions; the 
first three produced by three different dose-calculation algorithms (PB, CC and MC) 
and the fourth derived from experimental measurement using gel dosimetry.  The 
study is focused on comparing the relative dose distributions generated by the PB, CC 
and MC calculations and the gel measurement.  Two methods were used to compare 
these distributions: analysis of the dose-volume histograms of the two planning target 
volumes, and visualization of slices through 3D gamma maps produced for various 
pairs of dose cubes [32].   
 
As expected, the film measurements in a homogeneous water phantom, normalized in 
a region of low dose gradient within the primary PTV, showed agreement with 3% 
(for regions of low dose gradient) or 3 mm (for high gradient regions) with the PB, 
CC and MC dose calculations.  This illustrates that, for homogeneous media, all three 
dose calculations can be expected to give results that are identical within the errors of 
measurement and clinically equivalent. 
 
  9 of 20 
Relative normalization is applied to all of the inhomogeneous dose distributions 
presented here.  The aim of this study was to see if the calculation algorithm 
introduced significant errors into the shape of the dose distribution, rather than the 
absolute dosimetric level.  It must be emphasized that systematic absolute dosimetric 
differences do exist between the various dose calculation algorithms, but careful study 
of this is beyond the scope of this work.  Gel dosimetry is also not well suited to 
absolute dose measurement. 
 
Figure 3 shows cumulative dose-volume histograms (DVHs) of the primary and nodal 
planning target volumes, PTV1 and PTV2 respectively.  DVHs of PTV1 are also 
shown with the volume edited to explicitly exclude the air cavity that runs through the 
centre of the volume (fig 4a).  This was done for two reasons.  Firstly, a known 
limitation of PB algorithms is their handling of air cavities; variations in dose-to-air 
are, however, not of clinical significance, so by excluding the air cavity, differences in 
the DVHs indicate real difference in the dose to the target tissue (for instance, due to 
re-buildup effects).  Secondly the gel dose measurement implicitly excludes the air 
cavity anyway (since there was no gel present there), so accurate comparison of the 
gel-derived PTV must be performed with the modified PTV.  Three-dimensional 
gamma maps were calculated using a dose tolerance of 2% and a distance-to-
agreement of 2 mm.  Transaxial and coronal sections through the centres of these 
gamma maps are shown in figure 4.  The MC calculated dose distribution is compared 
in turn to the PB, CC and gel dose measurement.  Finally figure 5 shows dose profiles 
through the centers of the air cavity and bone insert for each of the methods. 
 
The poor performance of the PB algorithm inside the air cavity is nicely illustrated by 
figures 4a and 5.  The PB algorithm greatly over-estimates the dose to air, leading to a 
falsely sharp drop-off in the DVH at high dose.  Smaller discrepancies between the 
PB and MC calculations are also seen in the bone insert and right-hand portion of 
PTV2 in figure 4a, although the absolute dose error is still only 2–3%.  When the dose 
to air is excluded the DVHs of the PB and MC calculations in PTV1 are very similar 
(figure 3a). 
  
By contrast, the collapsed cone and Monte Carlo calculations show very close 
agreement across the entire phantom, although small absolute differences (2–3%) in 
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the dose to the air cavity and bone insert are still present.  The CC algorithm 
underestimates the dose to the air cavity with respect to the MC in this case, leading 
to an exaggerated drop in the CC DVH (figure 3b). With the air cavity excluded, the 
CC and MC DVHs are almost identical for PTV1, as is also the case for PTV2. This 
indicates that the collapsed cone calculation is perfectly adequate for clinical use, 
certainly within the 2%, 2 mm criteria in this analysis (with the dose normalized to the 
median in the PTV, excluding air).  These results agree with similar finding by Nisbet 
et al [33]. 
 
A reduction in 95% coverage is seen in the gel-measured DVHs for both PTV1 and 
PTV2 (Figs 3a and 3c).  The air cavity outline insode PTV1 was drawn exactly along 
the wall of the barex ―oesophagus‖ insert to allow the dose distributions to be 
compared in the interface region.  This could cause problems with the gel 
measurement due to i) surface oxygen poisoning of the gel in contact with the barex, 
ii) partial volume effects with the barex wall being counted as part of the gel 
dosimeter and iii) MR ringing artifacts close to the air / gel interface (which are 
clearly visible on the raw T2 images).  These apparent under-dose effects could be 
due to the reduced spatial resolution of the gel dose read-out (through slight mis-
registration of the dose distributions, diffusion of oxygen in the gel prior to 
polymerization or the relatively large MR slice thickness).  It should also be noted 
that all of the dose calculations were performed using a water-filled phantom, whereas 
in the experiment the phantom is filled with the slightly higher density gel.  The good 
agreement between the gel and MC dose distributions in the high dose region suggests 
that the discrepancy at lower dose could well be a surface effect around the air cavity.   
 
One other point of note can be drawn from figure 4c: a slightly higher gamma region 
can be seen in the low-dose concavity surrounded by PTV1 and PTV1.  The measured 
gel dose is clearly higher in this region than any of the calculations.  The reason for 
this is unclear; similar overdose was not seen in the film measurement.  One 
possibility may be the gel dose edge enhancement (overshoot) effect similar to that 
described by Vergote et al [34]; although they use a different type of gel.  The 
magnitude of the difference is however small at 2% so does not present a serious 
clinical concern.  Finally, agreement between the MC calculated and gel measured 
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doses to the spinal cord (i.e. down the centre of the gel-filled bone-equivalent insert) 
can be seen from figure 4c to be excellent.   
 
Figure 5 provides a summary of the results: starting from the left, the overestimate of 
dose in the air cavity by the PB calculation is clear; dose in the main portion of PTV1 
is then shown to be broadly similar by all methods, with the gel dose showing artifacts 
due to ringing in the MR image at the edge of the PTV.  Doses in the high-gradient 
region match well, as does the dose in the model spinal cord.  
 
 
4. Conclusions 
A phantom study was carried out investigating the relative dosimetric calculation 
accuracy for a typical head and neck IMRT beam arrangement.  Pencil beam, 
collapsed cone and Monte Carlo dose calculations were performed and compared with 
gel dosimetry measurement for an inhomogenous phantom containing both bone-
equivalent and air cavity inserts. 
 
The three-dimensional dose distributions produced were compared using dose-volume 
histograms of the planning target volumes and three-dimensional gamma maps (with 
distance-to-agreement and dosimetric tolerances of 2 mm and 2%).  Results indicate 
that, as expected the pencil-beam algorithm performs poorly around air cavities, 
leading to a significant overestimate of PTV coverage.  The collapsed-cone and 
Monte Carlo calculation both show very similar results, indicating that the collapsed-
cone algorithm is perfectly adequate for routine clinical use.  Generally good 
agreement is seen between the Monte Carlo calculated and gel measured dose 
distributions in the high dose regions and for the spinal cord, again suggesting 
confidence in this clinical class solution. 
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Figure 1:  Schematic diagram showing neck phantom design. 
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Figure 2:  Schematic diagram showing primary and nodal PTVs, air cavity and bone density 
insert.  The beam directions of the applied 5-field class solution are also indicated. 
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Figure 3: Dose volume histograms for the gel measurements and each of the dose calculation 
methods showing a) PTV1 excluding the air cavity, b) the whole of PTV1 and c) PTV2.  Inset 
figures show the MC-calculated dose in greyscale with the PTV highlighted in white. 
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Figure 4:  Transaxial and coronal slices through 3D gamma maps calculated using 
tolerances of 2 mm and 2% for a) Monte Carlo vs. Pencil Beam, b) Monte Carlo vs. 
Collapsed Cone and c) Monte Carlo vs. gel dose measurements. 
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Figure 5:  Dose profiles through the center of the air cavity and model spine for each of the 
different algorithms and the gel measurement.  The inset figure shows the gel dose map 
derived from MR and the position of the line section; note that the gel dose is undefined for 
the air cavity and bone insert. 
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